Get started
Evotec SEEvotec SEEvotec SE

Evotec SE

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsETFsBonds
Full chart
Full chart

Compare with Evotec SE



Key stats


Market capitalization
‪570.30 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.008 CHF
Net income (FY)
‪−96.39 M‬ CHF
Revenue (FY)
‪734.07 M‬ CHF
Shares float
‪148.11 M‬
Beta (1Y)
−1.05

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪4.55 K‬
Change (1Y)
−274−5.68%
Revenue / Employee (1Y)
‪161.23 K‬ CHF
Net income / Employee (1Y)
‪−21.17 K‬ CHF

Details


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Christian Wojczewski
Website
evotec.com
Headquarters
Hamburg
Founded
1998
IPO date
Oct 11, 1999
ISIN
DE0005664809
FIGI
BBG006TLPSS9
Identifiers
ISIN DE0005664809
CFI code
ESVUFB
Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


— YTM
Maturity dateMay 21, 2033
Coupon2.63% (Fixed)

See all EVT bonds 

ETFs holding the stock


WCMI
First Trust WCM International Equity ETF
Weight0.63%
Market value‪10.69 M‬
EXS2
iShares TecDAX (R) UCITS ETF (DE)
Weight0.47%
Market value‪3.30 M‬
EXIB
iShares TecDAX (R) UCITS ETF (DE) Units -EUR-
Weight0.47%
Market value‪3.30 M‬
C005
Amundi Index Solutions - SDAX UCITS ETF
Weight1.43%
Market value‪2.57 M‬
VGK
Vanguard FTSEEuropean ETF
Weight0.01%
Market value‪2.15 M‬
DISV
Dimensional International Small Cap Value ETF
Weight0.03%
Market value‪1.34 M‬
XXSC
Xtrackers MSCI Europe Small Cap UCITS ETF Capitalisation 1C
Weight0.04%
Market value‪1.33 M‬
MMS
Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF DIST
Weight0.18%
Market value‪1.29 M‬
CSEMUS.EUR
iShares MSCI EMU Small Cap UCITS ETF
Weight0.09%
Market value‪872.43 K‬
2B78
iShares Healthcare Innovation UCITS ETF
Weight0.07%
Market value‪806.44 K‬
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- Capitalisation
Weight0.09%
Market value‪681.82 K‬

Explore more ETFs 

Frequently asked questions


The current price of EVT is 4.500 CHF — it hasn't changed in the past 24 hours. Watch Evotec SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange Evotec SE stocks are traded under the ticker EVT.
EVT stock hasn't changed in a week, the month change is a −10.63% fall, over the last year Evotec SE has showed a −83.31% decrease.
We've gathered analysts' opinions on Evotec SE future price: according to them, EVT price has a max estimate of 9.24 CHF and a min estimate of 3.23 CHF. Watch EVT chart and read a more detailed Evotec SE stock forecast: see what analysts think of Evotec SE and suggest that you do with its stocks.
EVT reached its all-time high on Apr 8, 2019 with the price of 28.640 CHF, and its all-time low was 3.284 CHF and was reached on Mar 29, 2016. View more price dynamics on EVT chart.
See other stocks reaching their highest and lowest prices.
EVT stock is 0.00% volatile and has beta coefficient of −1.05. Track Evotec SE stock price on the chart and check out the list of the most volatile stocks — is Evotec SE there?
Today Evotec SE has the market capitalization of ‪570.17 M‬, it has decreased by −1.41% over the last week.
Yes, you can track Evotec SE financials in yearly and quarterly reports right on TradingView.
Evotec SE is going to release the next earnings report on Aug 13, 2026. Keep track of upcoming events with our Earnings Calendar.
EVT earnings for the last quarter are −0.64 CHF per share, whereas the estimation was −0.23 CHF resulting in a −181.63% surprise. The estimated earnings for the next quarter are −0.06 CHF per share. See more details about Evotec SE earnings.
Evotec SE revenue for the last quarter amounts to ‪144.62 M‬ CHF, despite the estimated figure of ‪160.72 M‬ CHF. In the next quarter, revenue is expected to reach ‪136.94 M‬ CHF.
EVT net income for the last quarter is ‪−112.59 M‬ CHF, while the quarter before that showed ‪13.62 M‬ CHF of net income which accounts for 0.00% change. Track more Evotec SE financial stats to get the full picture.
No, EVT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 25, 2026, the company has ‪4.55 K‬ employees. See our rating of the largest employees — is Evotec SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evotec SE EBITDA is ‪−23.38 M‬ CHF, and current EBITDA margin is −5.25%. See more stats in Evotec SE financial statements.
Like other stocks, EVT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evotec SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evotec SE technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evotec SE stock shows the sell signal. See more of Evotec SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.